An observational study in Dialysis and Kidney Transplantation, sponsored by Istituto Giannina Gaslini. Recruiting at 12 sites in Italy. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Istituto Giannina Gaslini · Observational
The primary aim of the Registry, in addition to promoting collaboration and the sharing of protocols among participating centres, is to collect epidemiological, clinical, and biochemical data on patients, as well as technical data on dialysis treatments performed at Italian dialysis centres.
Istituto Giannina Gaslini is the lead sponsor of 54 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation).
Exclusion criteria:
- Duration of kidney replacement therapy of less than 30 days before any potential drop-out.
Age under 18 years at the initiation of the first course of chronic kidney replacement therapy (dialysis or pre-emptive kidney transplantation)
Collection of epidemiological, clinical, and biochemical data from patients, as well as technical data regarding dialysis treatments across various Italian dialysis centers.
Time frame: through study completion, an average of 10 years
Plan to share: Undecided
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituto Giannina Gaslini